SRF reported a strong Q3 FY26 performance with consolidated revenue growing 6% YoY to ₹3,713 crore and PAT jumping 60% to ₹433 crore. The Chemicals business led growth with a 22% revenue increase to ₹1,825 crore, driven by record performance in Fluorochemicals and firm global HFC prices. Despite pricing pressures from Chinese competitors in Specialty Chemicals and Technical Textiles, the company maintained market share and improved operational efficiencies. The board approved a second interim dividend of ₹5 per share and a new ₹180 crore investment for a pharma intermediate plant at Dahej.

SRF Limited's Board of Directors has declared a second interim dividend of Rs 5.00 per equity share for the financial year 2025-26, representing a 50% payout on the paid-up capital. The company has fixed January 27, 2026, as the record date to identify eligible shareholders. The dividend distribution is scheduled to be completed on or before February 17, 2026. This announcement reflects the company's commitment to returning value to its shareholders through consistent payouts.

SRF Limited has announced a capital expenditure of Rs 180 crore for setting up a new Pharma Intermediate Plant (PIP-2) at its Dahej site in Gujarat. The facility will focus on precursor processes for pharmaceutical products to capture emerging business opportunities in the pharma sector. The project is expected to be completed by September 30, 2026. The investment will be funded through a mix of debt and internal accruals, reflecting the company's focus on high-growth specialty segments.

SRF Limited has announced the appointment of Mr. Samir Kashyap as its President and Chief Financial Officer (CFO), effective January 27, 2026. Mr. Kashyap is a seasoned professional with over 30 years of experience, including 20 years as a CFO at major global firms such as Meta, SAP, and Genpact. His background includes expertise in financial planning, M&A integration, and digital transformation across emerging and developed markets. This strategic appointment aims to bolster SRF's financial leadership and corporate governance.

SRF Limited has appointed Mr. Samir Kashyap as President and Chief Financial Officer (CFO), effective January 27, 2026. Mr. Kashyap brings over 30 years of experience, including 20 years in CFO roles at global organizations such as Meta, SAP, and Genpact. His expertise includes digital transformation, M&A integration, and managing profitability across diverse markets. This high-profile appointment is expected to bolster the company's financial leadership and strategic execution.

SRF Limited reported a strong performance for Q3 FY26, with consolidated revenue growing 6.3% YoY to ₹3,712.5 crore and Profit After Tax (PAT) jumping 59.6% to ₹432.7 crore. The Chemicals business was the primary driver, with segment revenue increasing 22% and EBIT rising 36.4% due to higher volumes in Fluorochemicals. However, the Packaging Films and Technical Textiles segments faced headwinds, with revenues declining 3.1% and 11% respectively due to pricing pressure and Chinese competition. The company also announced a new ₹180 crore capex for a Pharma Intermediates plant at Dahej to bolster its specialty chemicals portfolio.

SRF reported a strong Q3FY26 with PAT growing 60% YoY to ₹433 crore, primarily driven by a 36% jump in operating profit within the Chemicals segment. While the Fluorochemicals division saw record performance due to firm global HFC prices, the Specialty Chemicals and Technical Textiles segments faced headwinds from aggressive Chinese pricing. The company announced a second interim dividend of ₹5 per share and approved a ₹180 crore investment for a new Pharma Intermediates plant. Despite a ₹73 crore one-time impact from new labour codes, the overall bottom-line growth remains robust.

SRF Limited has announced the appointment of Samir Kashyap as its new President and Chief Financial Officer, effective January 27, 2026. Mr. Kashyap brings over 30 years of professional experience, including 20 years in CFO roles at major global firms like Meta, SAP, and Genpact. His expertise spans financial planning, digital transformation, M&A integration, and corporate governance. This leadership change is expected to strengthen the company's financial strategy and stakeholder management.

SRF Limited has announced its second interim dividend for the financial year 2025-26 at Rs 5 per equity share, which is 50% of the paid-up capital. The Board of Directors finalized this decision during their meeting on January 20, 2026. Shareholders appearing on the register as of the record date, January 27, 2026, will be eligible for the payout. The company expects to complete the dividend distribution by February 17, 2026.

SRF reported a strong performance for the quarter ended December 31, 2025, with standalone revenue growing 6.9% YoY to ₹2,951.68 crore. The bottom line saw a significant boost, with Net Profit rising 63.6% YoY to ₹457.91 crore, aided by a ₹99.12 crore tax adjustment from earlier years. The Chemicals Business remains the primary growth engine, with segment revenue increasing 23.7% YoY to ₹1,861.25 crore. However, the Packaging Films and Technical Textiles segments faced headwinds, reporting YoY revenue declines of 15.6% and 11.0% respectively.

SRF Limited has received a favorable ruling from the Income Tax Appellate Tribunal (ITAT) regarding the taxation of Carbon Emission Reduction Certificates (CERs). The tribunal ruled that CERs for AY 2011-12 and AY 2013-14 should be treated as capital receipts, making them non-taxable under the Income Tax Act. This outcome is expected to result in a significant reduction of the company's tax liability by approximately Rs 99 Crores. This positive development will likely improve the company's net profit and cash position once the adjustment is accounted for.